Abstract
Erratum to: Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have